Connection

James Chalmers to Pseudomonas Infections

Back to Details
This is a "connection" page, showing publications James Chalmers has written about Pseudomonas Infections.
James Chalmers
Connection Strength
1.475
Pseudomonas Infections
  1. The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J. 2018 02; 51(2).
    View in: PubMed
    Score: 0.501
  2. Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis. Respir Med. 2017 07; 128:1-6.
    View in: PubMed
    Score: 0.476
  3. Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials. Lancet Respir Med. 2019 03; 7(3):213-226.
    View in: PubMed
    Score: 0.134
  4. Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis. Respir Med. 2018 03; 136:111-117.
    View in: PubMed
    Score: 0.126
  5. A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa: A Proof of Concept Study. Chest. 2017 08; 152(2):368-378.
    View in: PubMed
    Score: 0.119
  6. Macrolide resistance in Pseudomonas aeruginosa: implications for practice. Eur Respir J. 2017 05; 49(5).
    View in: PubMed
    Score: 0.119
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.